Executive leadership team – Régis Mulot - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
    • Lay Summaries
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
Back

Post navigation

Previous
Next

Executive leadership team – Régis Mulot

© Ipsen Pharma. All rights reserved

Usage policy

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Executive leadership team – Régis Mulot

- 17 May 2023 - 1 mins read

© Ipsen Pharma. All rights reserved

Usage policy

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.

Post navigation

Previous
Next

Related Library

Executive leadership team – Laura Réveillon
14 May 2025 1 mins read

Executive leadership team – Laura Réveillon

Executive leadership team – Olivia Brown
01 April 2025 1 mins read

Executive leadership team – Olivia Brown

Executive leadership team – Josep Catllà 
20 August 2024 1 mins read

Executive leadership team – Josep Catllà 

Executive leadership team – Keira Driansky
13 May 2024 1 mins read

Executive leadership team – Keira Driansky

Executive leadership team – Christelle Huguet
25 September 2023 1 mins read

Executive leadership team – Christelle Huguet

Executive leadership team – Sandra Silvestri
17 May 2023 1 mins read

Executive leadership team – Sandra Silvestri

Executive leadership team – Mari Scheiffele
17 May 2023 1 mins read

Executive leadership team – Mari Scheiffele

Executive leadership team – Aidan Murphy
17 May 2023 1 mins read

Executive leadership team – Aidan Murphy

Executive leadership team – Philippe Lopes Fernandes
17 May 2023 1 mins read

Executive leadership team – Philippe Lopes Fernandes

Executive leadership team – Aymeric Le Chatelier
17 May 2023 1 mins read

Executive leadership team – Aymeric Le Chatelier

IPN price

€101.70

 €1.10 (1.09%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Sustainability
  • Patients
  • Stories
  • Annual Report
  • Contact us

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue